PTC Therapeutics, Inc.
PTCT
$71.70
-$0.27-0.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.23B | 1.89B | 1.95B | 1.71B | 2.00B |
| Total Receivables | 239.04M | 219.92M | 181.62M | 203.07M | 196.13M |
| Inventory | 91.35M | 75.57M | 79.65M | 52.69M | 34.06M |
| Prepaid Expenses | 57.88M | 66.05M | 58.51M | 44.73M | 42.85M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 8.80M | -- | -- |
| Total Current Assets | 2.62B | 2.25B | 2.27B | 2.01B | 2.27B |
|
|
|||||
| Total Current Assets | 2.62B | 2.25B | 2.27B | 2.01B | 2.27B |
| Net Property, Plant & Equipment | 126.27M | 129.43M | 135.42M | 137.65M | 113.35M |
| Long-term Investments | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M |
| Goodwill | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M |
| Total Other Intangibles | 402.93M | 380.68M | 388.75M | 396.47M | 143.81M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 21.58M | 22.65M | 18.30M | 19.44M | 21.78M |
| Total Assets | 3.25B | 2.87B | 2.90B | 2.64B | 2.63B |
|
|
|||||
| Total Accounts Payable | 40.45M | 25.48M | 45.49M | 36.62M | 26.51M |
| Total Accrued Expenses | 328.58M | 272.93M | 314.64M | 246.23M | 244.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 387.63M | 610.06M | 585.12M | 561.41M | 279.10M |
| Total Finance Division Other Current Liabilities | 14.41M | 15.13M | 23.19M | 21.99M | 77.99M |
| Total Other Current Liabilities | 14.41M | 15.13M | 23.19M | 21.99M | 77.99M |
| Total Current Liabilities | 771.07M | 923.60M | 968.43M | 866.25M | 627.81M |
|
|
|||||
| Total Current Liabilities | 771.07M | 923.60M | 968.43M | 866.25M | 627.81M |
| Long-Term Debt | 2.54B | 2.02B | 2.03B | 1.82B | 2.12B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 87.53M | 90.07M | 96.58M | 109.32M | 85.07M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 14.50M | 13.70M | 13.70M | 2.58M | 7.82M |
| Total Liabilities | 3.42B | 3.05B | 3.10B | 2.80B | 2.84B |
|
|
|||||
| Common Stock & APIC | 2.71B | 2.78B | 2.75B | 2.67B | 2.63B |
| Retained Earnings | -2.88B | -2.97B | -2.96B | -2.83B | -2.85B |
| Treasury Stock & Other | 6.02M | 8.47M | 10.50M | 5.93M | 7.36M |
| Total Common Equity | -165.36M | -180.47M | -205.31M | -155.76M | -206.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -165.36M | -180.47M | -205.31M | -155.76M | -206.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -165.36M | -180.47M | -205.31M | -155.76M | -206.55M |
|
|
|||||